Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 9
2004 3
2005 7
2006 6
2007 5
2008 6
2009 7
2010 3
2011 11
2012 14
2013 19
2014 8
2015 7
2016 7
2017 10
2018 12
2019 12
2020 7
2021 11
2022 12
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT; ESC Scientific Document Group. Catapano AL, et al. Eur Heart J. 2016 Oct 14;37(39):2999-3058. doi: 10.1093/eurheartj/ehw272. Epub 2016 Aug 27. Eur Heart J. 2016. PMID: 27567407 Free article. No abstract available.
Apport de la génomique dans la médecine de demain, applications cliniques et enjeux.
Laviolle B, Perche O, Gueyffier F; les participants à la table ronde « Recherche translationnelle » des Ateliers de Giens XXXIV. Laviolle B, et al. Among authors: gueyffier f. Therapie. 2019 Feb;74(1):1-8. doi: 10.1016/j.therap.2018.11.011. Epub 2018 Dec 16. Therapie. 2019. PMID: 30616902 Free article. French. No abstract available.
Limited evidence of physical therapy on balance after stroke: A systematic review and meta-analysis.
Hugues A, Di Marco J, Ribault S, Ardaillon H, Janiaud P, Xue Y, Zhu J, Pires J, Khademi H, Rubio L, Hernandez Bernal P, Bahar Y, Charvat H, Szulc P, Ciumas C, Won H, Cucherat M, Bonan I, Gueyffier F, Rode G. Hugues A, et al. Among authors: gueyffier f. PLoS One. 2019 Aug 29;14(8):e0221700. doi: 10.1371/journal.pone.0221700. eCollection 2019. PLoS One. 2019. PMID: 31465462 Free PMC article.
Type 2 diabetes.
Boussageon R, Roustit M, Gueyffier F, Tudrej BV, Rehman MB. Boussageon R, et al. Among authors: gueyffier f. Lancet. 2018 Mar 31;391(10127):1261. doi: 10.1016/S0140-6736(18)30702-5. Lancet. 2018. PMID: 29619958 No abstract available.
Recherche translationnelle : médecine personnalisée, médecine de précision, thérapies ciblées : marketing ou science ?
Marquet P, Longeray PH, Barlesi F; les participants à la table ronde N°1 de Giens XXX :; Ameye V, Augé P, Cazeneuve B, Chatelut E, Diaz I, Diviné M, Froguel P, Goni S, Gueyffier F, Hoog-Labouret N, Mourah S, Morin-Surroca M, Perche O, Perin-Dureau F, Pigeon M, Tisseau A, Verstuyft C. Marquet P, et al. Among authors: gueyffier f. Therapie. 2015 Jan-Feb;70(1):1-10. doi: 10.2515/therapie/2014230. Therapie. 2015. PMID: 27393393 French. No abstract available.
Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?
Lapeyre-Mestre M, Sapède C, Moore N; les participants à la table ronde N° 5 de Giens XXVIII :; Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, Plétan Y, Pons G, Verpillat P, Vigneau C. Lapeyre-Mestre M, et al. Among authors: gueyffier f. Therapie. 2013 Jul-Aug;68(4):241-6. doi: 10.2515/therapie/2013037. Therapie. 2013. PMID: 27392726 French. No abstract available.
Comment mesure-t-on le bénéfice net d’un traitement ?
Gueyffier F, Piedbois P, Bergmann JF; les participants à la table ronde n(o) 2 de Giens XXXII. Gueyffier F, et al. Therapie. 2017 Feb;72(1):39-49. doi: 10.1016/j.therap.2016.11.057. Epub 2017 Jan 3. Therapie. 2017. PMID: 28162245 French. No abstract available.
Population designations in biomedical research: Limitations and perspectives.
Gombault C, Grenet G, Segurel L, Duret L, Gueyffier F, Cathébras P, Pontier D, Mainbourg S, Sanchez-Mazas A, Lega JC. Gombault C, et al. Among authors: gueyffier f. HLA. 2023 Jan;101(1):3-15. doi: 10.1111/tan.14852. Epub 2022 Nov 5. HLA. 2023. PMID: 36258305 Free PMC article. Review.
171 results